ArticleBioinformatics (Oxford, England)2026
A hybrid neighborhood enhanced contrastive learning and self-knowledge distillation method for scRNA-seq data clustering analysis.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
motivationSingle-cell heterogeneity analysis faces significant challenges due to the high dimensionality, complexity, and noise inherent in scRNA-seq data, especially when aiming for precise cell type classification. Existing analytical methods often exhibit limited generalization ability and adaptability across different biological contexts, leading to biased identification of cell subpopulations and hindering a comprehensive understanding of diseases, therapeutic responses, and biological processes.
resultsTo address these issues, we propose a novel method named scKD, which integrates a hybrid neighbourhood-enhanced comparative learning model with a self-knowledge distillation strategy. scKD enhances clustering accuracy and is capable of accurately identifying both major cell types and rare cell subtypes. Extensive evaluations on multiple real-world datasets demonstrate that scKD achieves superior performance in subpopulation identification, clustering stability, and robustness. These results suggest that scKD is a powerful and reliable tool for analyzing single-cell transcriptomic data, facilitating deeper insights into cellular heterogeneity. AVAILABILITY: All datasets used in this study are publicly available. Detailed information about all the single-cell datasets analyzed in this paper is provided in Supplementary Table 1. All datasets can be accessed at https://zenodo.org/records/15412380. The source code is available at https://github.com/A-qlh/sckd. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.